Analyst firms · Piper Sandler · HCAT

Piper Sandler HCAT price target and rating history

Health Catalyst Inc (HCAT) · Technology

Piper Sandler rates Health Catalyst Inc (HCAT) Neutral with a $4 price target, as of its latest action on Aug 27, 2025. It has published 4 rating actions on HCAT since March 2022, including 1 upgrade and 2 downgrades.

Current rating
Neutral
Price target
$4
Median target, all firms
Too few
Actions on HCAT
4

Piper Sandler price target on HCAT

$38$21$42023202420252026
Piper Sandler price target on HCAT, each point a stated target, March 2022 to August 2025.

Every Piper Sandler rating on HCAT

How other firms rate HCAT

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Canaccord GenuityHold$1.80Aug 21, 2026
Wells FargoEqual Weight$1Mar 18, 2026

Questions about Piper Sandler and HCAT

What is Piper Sandler's price target for HCAT?
Piper Sandler's latest stated price target for Health Catalyst Inc (HCAT) is $4, from its action on Aug 27, 2025.
What is Piper Sandler's rating on HCAT?
Piper Sandler rates HCAT Neutral, a neutral rating, as of Aug 27, 2025.
When did Piper Sandler last change its view on HCAT?
On Aug 27, 2025, Piper Sandler downgrades to Neutral from Overweight, price target $4.

More HCAT rating histories

All Piper Sandler ratingsHCAT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.